Thoracic reirradiation with SBRT for residual/recurrent and new primary NSCLC within or immediately adjacent to a prior high-dose radiation field
- 1 May 2018
- journal article
- research article
- Published by Elsevier in Practical Radiation Oncology
- Vol. 8 (3) , e117-e123
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancerRadiation Oncology, 2013
- Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT)Radiation Oncology, 2013
- Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410JNCI: Journal of the National Cancer Institute, 2011
- The National Lung Screening Trial: Overview and Study DesignRadiology, 2011
- Stereotactic Body Radiation Therapy for Patients With Lung Cancer Previously Treated With Thoracic RadiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- A Phase I/II Radiation Dose Escalation Study With Concurrent Chemotherapy for Patients With Inoperable Stages I to III Non-Small-Cell Lung Cancer: Phase I Results of RTOG 0117International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Stereotactic Body Radiotherapy for Oligometastatic Lung TumorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional StudyJournal of Thoracic Oncology, 2007
- Second Primary Cancers in Patients with Stage III Non-Small Cell Lung Cancer Successfully Treated with Chemo-radiotherapyJapanese Journal of Clinical Oncology, 2005
- Non-small-cell lung cancer: reirradiation for loco-regional relapse previously treated with radiation therapyInternational Journal of Clinical Oncology, 2005